Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK

– Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) – Alvotech will be responsible for development and manufacture of the product  HYDERABAD, INDIA & REYKJAVIK, ICELAND (May 21, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development […]

Omnicell Announces XT Amplify

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas–(BUSINESS WIRE)– Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care […]

SoftWriters Set to Host First-Ever AI Mastermind Cohort

This strategic meeting will gather some of the top minds on AI within LTC Pharmacy Pittsburgh, PA – May 7, 2024 – SoftWriters, the leading provider of pharmacy management software for long-term care (LTC) pharmacies, is proud to announce its first-ever AI Mastermind Cohort, scheduled to take place from May 21 to May 23, 2024, […]

Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform

MALVERN, Pa., May 6, 2024 /PRNewswire/ — Endo, Inc. announced today that its Endo Injectable Solutions business unit launched its enhanced ready-to-use product line and platform, TruDelivery®, underscoring the company’s commitment to building its ready-to-administer and ready-to-use portfolio. “As the name suggests, TruDelivery delivers—without mixing, compounding, or diluting—so our customers can focus on quality patient […]

Dr. Reddy’s Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S.

Hyderabad India; May 3, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA® (doxycycline, USP) Capsules, 40 mg approved by the […]

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories

Gurugram and Hyderabad, India, April 25, 2024: Nestlé India Limited  (BSE : 500790, NSE: NESTLEIND) referred hereafter as “Nestlé India” and Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), both together referred as “JV Partners”, today announced that they have entered […]

Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose

Company launches generic equivalent to OTC NARCAN® Nasal Spray Provides convenient, affordable access to life-saving medicine BRIDGEWATER, N.J., Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the availability of Over the Counter (“OTC”) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food […]

SoftWriters Announces the Availability of New Delivery Integration with VirtueTechnologies

This is an exclusive strategic partnership with VirtueTechnologies — a logistics and delivery management solutions provider.  Pittsburgh, PA, April 22, 2024 –  SoftWriters, Inc., the leading provider of software solutions to LTC pharmacies, announces the official availability of a new partner integration between FrameworkLTC and Virtue Technologies, a logistics and delivery management solution exclusively available […]

Endo, Inc. Completes Acquisition of Endo International plc’s Assets

MALVERN, Pa., April 23, 2024  /PRNewswire/ — Endo, Inc. (“Endo” or the “Company”), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of substantially all of the assets of Endo International plc (“EIP”), as contemplated under EIP’s plan of reorganization (the “Plan”). With the Plan’s effectiveness, EIP’s operating assets […]

Cintas Builds Generative AI-Powered Internal Knowledge Center With Google Cloud

Expanded partnership will improve employee-partner and customer experience with Vertex AI Search CINCINNATI, OH and Cloud Next ’24, LAS VEGAS – Cintas Corporation (NASDAQ: CTAS), a leading provider of business to business services, and Google Cloud today announced an expanded partnership to support Cintas’ ongoing digital transformation. Cintas will leverage Vertex AI–Google Cloud’s generative AI […]

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Cintas Builds Generative AI-Powered Internal Knowledge Center With Google Cloud

Name
Address
Subscribe